• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自土耳其队列的 COVID-19 时间事件数据的风险因素综合排名。

A composite ranking of risk factors for COVID-19 time-to-event data from a Turkish cohort.

机构信息

Department of Biostatistics, Faculty of Medicine, Girne American University, Karmi, Cyprus.

Department of Biostatistics, Faculty of Medicine, Tokat Gaziosmanpasa University, Turkey.

出版信息

Comput Biol Chem. 2022 Jun;98:107681. doi: 10.1016/j.compbiolchem.2022.107681. Epub 2022 Apr 9.

DOI:10.1016/j.compbiolchem.2022.107681
PMID:35487152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8993420/
Abstract

Having a complete and reliable list of risk factors from routine laboratory blood test for COVID-19 disease severity and mortality is important for patient care and hospital management. It is common to use meta-analysis to combine analysis results from different studies to make it more reproducible. In this paper, we propose to run multiple analyses on the same set of data to produce a more robust list of risk factors. With our time-to-event survival data, the standard survival analysis were extended in three directions. The first is to extend from tests and corresponding p-values to machine learning and their prediction performance. The second is to extend from single-variable to multiple-variable analysis. The third is to expand from analyzing time-to-decease data with death as the event of interest to analyzing time-to-hospital-release data to treat early recovery as a meaningful event as well. Our extension of the type of analyses leads to ten ranking lists. We conclude that 20 out of 30 factors are deemed to be reliably associated to faster-death or faster-recovery. Considering correlation among factors and evidenced by stepwise variable selection in random survival forest, 10 ~ 15 factors seem to be able to achieve the optimal prognosis performance. Our final list of risk factors contain calcium, white blood cell and neutrophils count, urea and creatine, d-dimer, red cell distribution widths, age, ferritin, glucose, lactate dehydrogenase, lymphocyte, basophils, anemia related factors (hemoglobin, hematocrit, mean corpuscular hemoglobin concentration), sodium, potassium, eosinophils, and aspartate aminotransferase.

摘要

拥有一份完整可靠的、来自常规实验室血液检测的新冠肺炎疾病严重程度和死亡率风险因素清单,对于患者护理和医院管理非常重要。通常使用荟萃分析来合并来自不同研究的分析结果,以使其更具可重复性。在本文中,我们建议对同一组数据进行多次分析,以生成更稳健的风险因素清单。对于我们的生存时间事件数据,标准生存分析在三个方向上进行了扩展。第一个方向是将测试及其对应的 p 值扩展到机器学习及其预测性能。第二个方向是将单变量分析扩展到多变量分析。第三个方向是将分析死亡时间数据扩展到分析住院释放时间数据,以将早期恢复视为有意义的事件。我们对分析类型的扩展导致了十个排名列表。我们得出结论,30 个因素中有 20 个被认为与更快的死亡或更快的恢复相关。考虑到因素之间的相关性,并通过随机生存森林中的逐步变量选择得到证实,10~15 个因素似乎能够达到最佳预后性能。我们最终的风险因素清单包括钙、白细胞和中性粒细胞计数、尿素和肌酸、D-二聚体、红细胞分布宽度、年龄、铁蛋白、葡萄糖、乳酸脱氢酶、淋巴细胞、嗜碱性粒细胞、贫血相关因素(血红蛋白、血细胞比容、平均红细胞血红蛋白浓度)、钠、钾、嗜酸性粒细胞和天冬氨酸氨基转移酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/f3bd05c85882/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/ec2a5df3dff3/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/d5b1424056cc/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/321123bf6c07/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/f3bd05c85882/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/ec2a5df3dff3/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/d5b1424056cc/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/321123bf6c07/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/8993420/f3bd05c85882/gr3_lrg.jpg

相似文献

1
A composite ranking of risk factors for COVID-19 time-to-event data from a Turkish cohort.来自土耳其队列的 COVID-19 时间事件数据的风险因素综合排名。
Comput Biol Chem. 2022 Jun;98:107681. doi: 10.1016/j.compbiolchem.2022.107681. Epub 2022 Apr 9.
2
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).同种异体人牙髓干细胞治疗重症 COVID-19 患者的安全性和有效性评估:一项随机对照试验(I/II 期)研究方案的结构化总结
Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.COVID-19 成年住院患者幸存者和非幸存者实验室标志物的时间变化。
BMC Infect Dis. 2020 Dec 11;20(1):952. doi: 10.1186/s12879-020-05678-0.
5
Routine laboratory testing to determine if a patient has COVID-19.进行常规实验室检测以确定患者是否感染新冠病毒。
Cochrane Database Syst Rev. 2020 Nov 19;11(11):CD013787. doi: 10.1002/14651858.CD013787.
6
[Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].[老年重症新型冠状病毒肺炎患者继发噬血细胞性淋巴组织细胞增生症的临床特征及危险因素:一项多中心回顾性队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):793-799. doi: 10.3760/cma.j.cn121430-20230510-00158.
7
Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.意大利瓦尔卡莫尼卡地区预测 2019 年冠状病毒病(COVID-19)死亡的实验室指标。
Clin Chem Lab Med. 2020 Jun 25;58(7):1100-1105. doi: 10.1515/cclm-2020-0459.
8
How do routine laboratory tests change in coronavirus disease 2019?常规实验室检查在 2019 冠状病毒病中有哪些变化?
Scand J Clin Lab Invest. 2021 Feb;81(1):24-33. doi: 10.1080/00365513.2020.1855470. Epub 2020 Dec 20.
9
[Multicenter retrospect analysis of early clinical features and analysis of risk factors on prognosis of elderly patients with severe burns].老年重度烧伤患者早期临床特征的多中心回顾性分析及预后危险因素分析
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024 Mar 20;40(3):249-257. doi: 10.3760/cma.j.cn501225-20230808-00042.
10
IL-6-based mortality risk model for hospitalized patients with COVID-19.基于 IL-6 的 COVID-19 住院患者死亡风险模型。
J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22.

引用本文的文献

1
Osmolality as a strong predictor of COVID-19 mortality and its possible links to other biomarkers.渗透压作为新冠病毒疾病死亡率的有力预测指标及其与其他生物标志物的可能联系。
PLoS One. 2025 Sep 16;20(9):e0331344. doi: 10.1371/journal.pone.0331344. eCollection 2025.
2
Red Cell Distribution Width (RDW), Platelets and Platelet Index MPV/PLT Ratio as Specific Time Point Predictive Variables of Survival Outcomes in COVID-19 Hospitalized Patients.红细胞分布宽度(RDW)、血小板及血小板指数MPV/PLT比值作为COVID-19住院患者生存结局的特定时间点预测变量
J Clin Med. 2025 Jul 30;14(15):5381. doi: 10.3390/jcm14155381.
3
Diabetes and bacterial co-infection are two independent risk factors for respiratory syncytial virus disease severity.

本文引用的文献

1
Approximate reciprocal relationship between two cause-specific hazard ratios in COVID-19 data with mutually exclusive events.在具有互斥事件的COVID-19数据中,两个特定病因风险比之间的近似倒数关系。
Int J Biostat. 2023 Apr 3;20(1):43-56. doi: 10.1515/ijb-2022-0083. eCollection 2024 May 1.
2
Sugar is not always sweet: exploring the relationship between hyperglycemia and COVID-19 in a predominantly African American population.糖并不总是甜的:在以非裔美国人为主的人群中探索高血糖与 COVID-19 之间的关系。
BMJ Open Diabetes Res Care. 2022 Aug;10(4). doi: 10.1136/bmjdrc-2021-002692.
3
A Meta-Analysis: Coronary Artery Calcium Score and COVID-19 Prognosis.
糖尿病和细菌合并感染是呼吸道合胞病毒疾病严重程度的两个独立危险因素。
Front Med (Lausanne). 2023 Nov 1;10:1231641. doi: 10.3389/fmed.2023.1231641. eCollection 2023.
4
Blood-Type-A is a COVID-19 infection and hospitalization risk in a Turkish cohort.A型血是土耳其队列中 COVID-19 感染和住院的风险因素。
Transfus Clin Biol. 2023 Feb;30(1):116-122. doi: 10.1016/j.tracli.2022.10.003. Epub 2022 Oct 13.
一项荟萃分析:冠状动脉钙评分与 COVID-19 预后。
Med Sci (Basel). 2022 Jan 21;10(1):5. doi: 10.3390/medsci10010005.
4
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.COVID-19 血液图谱定义了疾病严重程度和特异性的特征。
Cell. 2022 Mar 3;185(5):916-938.e58. doi: 10.1016/j.cell.2022.01.012. Epub 2022 Jan 21.
5
QCovSML: A reliable COVID-19 detection system using CBC biomarkers by a stacking machine learning model.QCovSML:一种通过堆叠机器学习模型使用全血细胞计数生物标志物的可靠的新冠病毒检测系统。
Comput Biol Med. 2022 Apr;143:105284. doi: 10.1016/j.compbiomed.2022.105284. Epub 2022 Feb 12.
6
Neutrophil-to-lymphocyte ratio and D-dimer are biomarkers of death risk in severe COVID-19: A retrospective observational study.中性粒细胞与淋巴细胞比值和D-二聚体是重症新型冠状病毒肺炎死亡风险的生物标志物:一项回顾性观察研究。
Health Sci Rep. 2022 Feb 9;5(2):e514. doi: 10.1002/hsr2.514. eCollection 2022 Mar.
7
Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19.乳酸脱氢酶水平升高和高血压与新冠病毒疾病的重症相关。
World J Clin Cases. 2022 Jan 7;10(1):128-135. doi: 10.12998/wjcc.v10.i1.128.
8
Red blood cell distribution width: A severity indicator in patients with COVID-19.红细胞分布宽度:COVID-19 患者的严重程度指标。
J Med Virol. 2022 May;94(5):2133-2138. doi: 10.1002/jmv.27602. Epub 2022 Jan 31.
9
SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids.SARS-CoV-2 感染人类肾脏并导致肾类器官纤维化。
Cell Stem Cell. 2022 Feb 3;29(2):217-231.e8. doi: 10.1016/j.stem.2021.12.010. Epub 2021 Dec 25.
10
Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis.血清铁蛋白作为 COVID-19 的预测生物标志物:系统评价、荟萃分析和荟萃回归分析。
J Crit Care. 2022 Feb;67:172-181. doi: 10.1016/j.jcrc.2021.09.023. Epub 2021 Nov 20.